Capital Investment Advisors LLC lessened its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 3.4% during the 2nd quarter, HoldingsChannel.com reports. Capital Investment Advisors LLC’s holdings in Vertex Pharmaceuticals were worth $444,000 at the end of the most recent quarter. Vertex Pharmaceuticals Profile(Free Report)Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report). Receive News & Ratings for Vertex Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vertex Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.